Acute viral parotitis (mumps) prevention is achieved with which vaccine schedule?

Acute viral parotitis (mumps) prevention is achieved with which vaccine schedule?

• A. DTaP vaccine given at 2, 4, and 6 months
• B. Hepatitis B vaccine series
• C. MMR vaccine given in two doses at 12-15 months and 4-6 years
• D. Polio vaccine series

Answer: (C)

The vaccine that prevents mumps is the MMR vaccine, which covers measles, mumps, and rubella with a live attenuated formulation. To build strong and lasting immunity, the recommended schedule is two doses: the first around 12 to 15 months of age and the second around 4 to 6 years of age, typically before school entry. This two-dose series increases protection against mumps to the high 90s percent, reducing the risk of acute viral parotitis and its potential complications. The other vaccines listed protect against different diseases (DTaP for diphtheria, tetanus, pertussis; hepatitis B; polio) and do not include mumps, so they don’t prevent mumps.

The vaccine that prevents mumps is the MMR vaccine, which covers measles, mumps, and rubella with a live attenuated formulation. To build strong and lasting immunity, the recommended schedule is two doses: the first around 12 to 15 months of age and the second around 4 to 6 years of age, typically before school entry. This two-dose series increases protection against mumps to the high 90s percent, reducing the risk of acute viral parotitis and its potential complications. The other vaccines listed protect against different diseases (DTaP for diphtheria, tetanus, pertussis; hepatitis B; polio) and do not include mumps, so they don’t prevent mumps.